Nearly two years ago, Charles River Laboratories (CRL) paid $800 million for a company called MPI Research to bolster its business running clinical trials for drug makers and other companies. But Charles River did not know one MPI employee was an also undercover agent for the Humane Society of the United States and secretly filmed experiments conducted on various dogs, which were later publicized on the internet.
Now, a small biotech that was a Charles River client has filed a lawsuit accusing the big clinical research organization of allowing its confidential trade secrets to be widely disseminated and compromising its business, which focuses on finding a treatment for mesothelioma, a type of cancer. And as a result of this episode, Paredox Therapeutics claimed it was forced to revamp its operations at a “vast” cost.
About the Author Reprints
